Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
GLYC | GLYCOMIMETICS INC | United States | $17.41M | 64,464,412 | 19.61% | 80.39% | Net Buying | Net Buying |
INTZ | INTRUSION INC | United States | $9.32M | 4,904,195 | 0.23% | 99.77% | Net Buying | Net Buying |
ASLN | ASLAN PHARMACEUTICALS LTD | Singapore | $7.47M | 466,761,105 | 0.18% | 0.00% | ||
PPBT | PURPLE BIOTECH LTD | Israel | $9.92M | 198,386,080 | 0.15% | 0.00% | ||
YTEN | YIELD10 BIOSCIENCE INC | United States | $1.85M | 642,546 | 1.99% | 98.01% | Net Buying | |
IQ | IQIYI INC | China | $4.96B | 6,716,137,085 | 3.18% | 0.00% | ||
BPTH | BIO-PATH HOLDINGS INC | United States | $3.71M | 1,656,235 | 0.10% | 99.90% | ||
CLNN | CLENE INC | United States | $49.19M | 128,433,721 | 4.09% | 52.66% | Net Buying | Net Selling |
BIOL | BIOLASE INC | United States | $5.14M | 33,394,979 | 0.77% | 55.47% | ||
BNED | BARNES & NOBLE EDUCATION INC | United States | $10.10M | 53,156,369 | 10.25% | 89.75% | Net Selling | |
LIFE | ATYR PHARMA INC | United States | $132.16M | 69,010,940 | 38.06% | 22.13% | Net Buying | |
LYRA | LYRA THERAPEUTICS INC | United States | $21.70M | 60,964,859 | 11.98% | 14.19% | Net Buying | |
DARE | DARE BIOSCIENCE INC | United States | $36.39M | 101,092,900 | 6.16% | 25.30% | ||
APLM | APOLLOMICS INC | United States | $30.70M | 89,495,790 | 0.74% | 0.00% | ||
APTO | APTOSE BIOSCIENCES INC | Canada | $19.25M | 16,309,393 | 4.99% | 65.32% | Net Buying | |
CKPT | CHECKPOINT THERAPEUTICS INC | United States | $60.07M | 36,850,279 | 6.10% | 7.77% | Net Selling | Net Selling |
GOSS | GOSSAMER BIO INC | United States | $167.85M | 226,218,652 | 31.98% | 14.47% | Net Buying | Net Selling |
OCUP | OCUPHIRE PHARMA INC | United States | $44.85M | 25,924,158 | 0.89% | 99.11% | Net Buying | Net Buying |
RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | United States | $47.74M | 27,918,560 | 6.08% | 38.25% | ||
MVST | MICROVAST HOLDINGS INC | United States | $131.95M | 317,196,095 | 14.10% | 31.20% | Net Selling | |
EOSE | EOS ENERGY ENTERPRISES INC | United States | $150.48M | 208,127,550 | 28.32% | 13.96% | Net Selling | Net Buying |
SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | United States | $5.57M | 3,112,401 | 1.03% | 98.97% | Net Buying | |
VIRX | VIRACTA THERAPEUTICS INC | United States | $32.99M | 39,272,434 | 1.07% | 98.93% | Net Buying | Net Selling |
LUMO | LUMOS PHARMA INC | United States | $18.18M | 8,116,488 | 11.54% | 88.46% | Net Buying | Net Buying |
SYBX | SYNLOGIC INC | United States | $20.14M | 11,707,011 | 0.54% | 99.46% | Net Selling | Net Selling |
GOEV | CANOO INC | United States | $181.70M | 68,567,495 | 4.36% | 95.64% | Net Buying | |
FEMY | FEMASYS INC | United States | $29.55M | 22,220,718 | 5.82% | 8.01% | ||
MIST | MILESTONE PHARMACEUTICALS INC | Canada | $92.14M | 53,260,467 | 16.07% | 24.11% | ||
CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $11.92M | 50,924,284 | 3.06% | 34.31% | Net Selling | Net Buying |
IMRX | IMMUNEERING CORP | United States | $46.56M | 29,653,355 | 14.14% | 46.80% | Net Selling | Net Selling |
GNLX | GENELUX CORP | United States | $98.27M | 26,996,740 | 18.73% | 5.19% | Net Selling | Net Selling |
PRST | PRESTO AUTOMATION INC | United States | $12.77M | 80,791,967 | 7.69% | 68.69% | Net Buying | |
CARA | CARA THERAPEUTICS INC | United States | $41.55M | 54,675,954 | 26.49% | 53.39% | Net Selling | Net Selling |
ACET | ADICET BIO INC | United States | $115.04M | 82,173,503 | 27.45% | 19.49% | Net Buying | |
GEVO | GEVO INC | United States | $168.20M | 236,232,717 | 24.12% | 11.14% | Net Selling | |
CVKD | CADRENAL THERAPEUTICS INC | United States | $7.09M | 16,008,469 | 1.56% | 46.72% | Net Buying | |
MRNS | MARINUS PHARMACEUTICALS INC | United States | $73.06M | 54,933,774 | 42.82% | 21.62% | Net Buying | Net Buying |
AMPX | AMPRIUS TECHNOLOGIES INC | United States | $124.70M | 94,472,655 | 4.33% | 75.78% | Net Selling | Net Buying |
AQMS | AQUA METALS INC | United States | $45.40M | 113,226,006 | 15.97% | 15.25% | Net Selling | |
NTBL | NOTABLE LABS LTD | Israel | $9.74M | 9,018,261 | 1.95% | 98.05% | Net Selling | |
TPST | TEMPEST THERAPEUTICS INC | United States | $75.09M | 22,217,265 | 2.95% | 97.05% | ||
INAB | IN8BIO INC | United States | $49.86M | 44,123,949 | 16.42% | 51.06% | Net Buying | |
DDC | DDC ENTERPRISE LTD | China | N/A | 20,158,176 | 0.78% | 0.00% | ||
OTLK | OUTLOOK THERAPEUTICS INC | United States | $173.90M | 23,405,637 | 1.30% | 98.70% | Net Buying | Net Buying |
FBIO | FORTRESS BIOTECH INC | United States | $34.65M | 19,916,124 | 12.17% | 60.54% | Net Buying | Net Buying |
VOR | VOR BIOPHARMA INC | United States | $118.77M | 68,259,602 | 24.85% | 10.15% | Net Selling | Net Selling |
TARA | PROTARA THERAPEUTICS INC | United States | $76.39M | 20,589,976 | 3.21% | 96.79% | Net Selling | Net Selling |
IKNA | IKENA ONCOLOGY INC | United States | $64.42M | 48,258,111 | 30.28% | 18.22% | ||
MBRX | MOLECULIN BIOTECH INC | United States | $11.37M | 2,311,536 | 1.74% | 98.26% | Net Buying | |
SGMT | SAGIMET BIOSCIENCES INC | United States | $147.44M | 31,913,887 | 27.36% | 67.96% | Net Buying | Net Buying |
SPRB | SPRUCE BIOSCIENCES INC | United States | $32.92M | 41,154,799 | 29.55% | 44.89% | Net Selling | Net Selling |
CMPS | COMPASS PATHWAYS PLC | United Kingdom | $566.19M | 68,380,857 | 14.07% | 50.20% | Net Selling | Net Selling |
CMMB | CHEMOMAB THERAPEUTICS LTD | Israel | $12.40M | 284,379,960 | 0.03% | 5.95% | ||
AGEN | AGENUS INC | United States | $226.37M | 20,999,261 | 46.57% | 53.43% | Net Buying | Net Buying |
NOTV | INOTIV INC | United States | $58.18M | 25,971,450 | 14.42% | 43.41% | Net Buying | |
PGEN | PRECIGEN INC | United States | $363.48M | 252,419,690 | 13.41% | 72.43% | Net Buying | Net Selling |
SBEV | SPLASH BEVERAGE GROUP INC | United States | $13.68M | 47,656,088 | 5.58% | 2.91% | Net Buying | |
IPA | IMMUNOPRECISE ANTIBODIES LTD | Canada | $30.21M | 26,315,260 | 6.04% | 0.00% | ||
SGMO | SANGAMO THERAPEUTICS INC | United States | $120.36M | 207,510,076 | 33.26% | 15.51% | Net Selling | Net Selling |
GRTS | GRITSTONE BIO INC | United States | $81.43M | 108,569,374 | 21.39% | 20.10% | Net Buying |